Tracers / [123I]beta-CIT
[123I]beta-CIT
Also written as [123I]beta-CIT; [I-123]beta-CIT
- Radionuclide
- I-123 t½ 792 min
- Modality
- SPECT
- Production route
- —
- Stage
- —
- Syntheses indexed
- 1
What it is
- Compound class
- —
- Target / mechanism
- —
- Clinical application
- —
- Theranostic pair
- —
Regulatory status
- FDA
- —
- EMA (centralised)
- —
- Other approvals
- —
- Brand names
- —
Clinical use
- Typical injected activity
- —
- Uptake time
- —
Reported in the literature. Not a dosing recommendation.
Published syntheses
| Module | Cassette | Purification | Yield % | RCP % | Precursor / supplier | Source |
|---|---|---|---|---|---|---|
| — | — | — | — | — | — | 17504864 2007 J Nucl Med |
Need this precursor?We can point you to suppliers for [123I]beta-CIT, or handle the enquiry for you.
Get in touchQuality control Preliminary — inferred from compound class
- Ph. Eur. monograph
- —
- USP monograph
- —
How this set was arrived at. base set per Ph. Eur. general monograph 0125 (rule); organic-phase radiosynthesis assumed from isotope/compound class, no synthesis data confirming it -> GC residual solvents (preliminary)
Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived
Setting up quality control?We can help you scope the equipment needed to release [123I]beta-CIT.
Get in touchNotes
Added from reverse module search (stage 6); 1 article(s) with I-123.